Bariatric Surgery
If you have been struggling with your weight, and diet and exercise have not yielded the desired results, there are a variety of options available to you, including bariatric surgery. Bariatric surgery may encompass a variety of procedures, which are collectively designed to help you lose weight. One common form of bariatric surgery is known as gastric bypass, which involves changing how your digestive system operates. Through these changes, your body may be better equipped to lose weight and maintain a healthier lifestyle. Bariatric surgery may also be recommended if you are experiencing health problems due to your weight. By speaking to your healthcare provider about the benefits and risks of these procedures, you can make a more informed decision about the best course of action for your personal health and wellness needs.
News


Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to substantial weight loss in people with Type 2 diabetes. The study included adults with Type 2 diabetes who were not taking diabetes medicines and whose blood sugar was not adequately controlled with diet and exercise alone.

If A GLP-1 Medication Has Changed Your Life For The Better, We Want To Hear About It
Whether it’s been about weight, blood sugar, PCOS, food noise, or something else entirely, we want to hear.View Entire Post ›

Study Compares GLP-1 Drugs on Their Benefits, Harms
(MedPage Today) — Variable weight-loss and cardiovascular benefits were seen with GLP-1 drugs in a systematic review and network meta-analysis, but effects on quality of life were less clear.
Across 262 randomized studies published through November…

Newer Diabetes Drugs, Including GLP-1 Agonists, Tied to Autoimmunity Risk
Friday, July 10 – (MedPage Today) — Analysis of hundreds of thousands of patient records showed differing risks for autoimmune disorders for new users of the more recent types of antidiabetic medications.
Rates of new-onset autoimmune conditions were compared…

GLP-1 use hits record high as Medicare opens access to weight-loss drugs
Friday, July 10 – The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%.

Societies combine to issue recommendations on use of incretin drugs in obesity therapy
Friday, July 10 – Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The statement, which is published in The Lancet Diabetes & Endocrinology, is led by Dr. Laurence Dobbie of the Department of Population Health Sciences, King’s College London, with an international team of 26 authors.

Medicare prescriptions for Wegovy jumped after approval for heart disease
Friday, July 10 – Medicare prescriptions for Wegovy increased sharply after the program started covering the anti-obesity medication to prevent heart problems, but just a fraction of beneficiaries likely eligible received the treatment, according to new research published in the American Journal of Managed Care by the USC Schaeffer Center for Health Policy & Economics.

GLP-1s and Liver Cancer Recurrence; IBS Acupuncture; Transmural Healing in Crohn’s
Friday, July 10 – (MedPage Today) — Diabetes patients with hepatocellular carcinoma (HCC) experienced longer time to HCC recurrence and longer survival when they initiated a GLP-1 agonist rather than a DPP-4 inhibitor, a target trial emulation study found. (Gut…
Reviews
- Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007 Aug 23;357(8):753-61. doi: 10.1056/NEJMoa066603. PMID: 17715409.
- Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013 Oct 22;347:f5934. doi: 10.1136/bmj.f5934. PMID: 24149519; PMCID: PMC3806364.
- Courcoulas AP, Christian NJ, Belle SH, Berk PD, Flum DR, Garcia L, Horlick M, Kalarchian MA, King WC, Mitchell JE, Patterson EJ, Pender JR, Pomp A, Pories WJ, Thirlby RC, Yanovski SZ, Wolfe BM; Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013 Dec 11;310(22):2416-25. doi: 10.1001/jama.2013.280928. PMID: 24189773; PMCID: PMC3955952.
- Brito JP, Montori VM, Davis AM. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. JAMA. 2017 Feb 14;317(6):635-636. doi: 10.1001/jama.2016.20563. PMID: 28196240; PMCID: PMC5557277.
- Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and Risks of Bariatric Surgery in Adults: A Review. JAMA. 2020 Sep 1;324(9):879-887. doi: 10.1001/jama.2020.12567. PMID: 32870301.
References:
- Wikipedia Bariatric surgery. Accessed September 2023
- Agency for Healthcare Research and Quality. Accessed September 2023
- American Society for Metabolic and Bariatric Surgery. “Bariatric Surgery Procedures.” Accessed September 2023